"At Schaumburg Dermatology our goal is to treat, maintain and enhance people’s lives by delivering medical and cosmetic dermatologic care in a unique way. We offer university-level quality care combined with a personal and compassionate atmosphere of a solo practice. In addition to determining solutions for acute and chronic concerns our Providers are dedicated to providing ongoing education regarding skin health. Our goal is to build strong relationships with local primary care physicians, specialists, and the community to exceed patient expectations, deliver positive outcomes, and increase skin health awareness."

During the past decade, Schaumburg Dermatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Schaumburg Dermatology" #1 sponsor was "Pfizer" with 2 trials, followed by "Astellas Pharma Inc" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored and "Stiefel, a GSK Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schaumburg Dermatology" #1 collaborator was "Basilea Pharmaceutica" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Schaumburg Dermatology" are "Psoriasis" (5 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Schaumburg Dermatology" in a lesser frequency.

Most popular intervention types in "Schaumburg Dermatology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "CP-690,550" (2 trials), "Alefacept exposure" (1 trials), "Placebo" (1 trials), "Placebo/CP-690,550" (1 trials) and "alitretinoin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schaumburg Dermatology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Schaumburg Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Schaumburg Dermatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Schaumburg Dermatology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".